Home/Filings/4/0001562180-17-002004
4//SEC Filing

Syndax Pharmaceuticals Inc 4

Accession 0001562180-17-002004

$SNDXCIK 0001395937operating

Filed

May 18, 8:00 PM ET

Accepted

May 19, 11:26 AM ET

Size

7.6 KB

Accession

0001562180-17-002004

Insider Transaction Report

Form 4
Period: 2017-05-17
Chen Henry
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-05-17+10,00010,000 total
    Exercise: $13.58From: 2018-05-17Exp: 2027-05-17Common Stock (10,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2017-05-17+5,0005,000 total
    Exercise: $13.58Exp: 2027-05-17Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]1/36th of the shares subject to the option shall vest monthly over a three-year period.

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001395937

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 11:26 AM ET
Size
7.6 KB